STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1516479

Insys Therapeutics, Inc.
CIK 0001516479 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
54.4
composite ยท 1 signals ยท CLEAN

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-05 ยท FY 2016-12-31 ยท CLEAN54.4

Tax arbitrage

[FY2016 data, stale โ€” no more recent pretax-income figure in XBRL] ETR 9.9% โ€” within normal range of statutory
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2019-03-13) โ†—
Evidence โ€” inputs and thresholds
{
  "etr_by_year": {
    "2016-12-31": 0.099
  },
  "statutory_rate": 0.21,
  "gap_by_year": {
    "2016-12-31": 0.111
  },
  "note": "Low ETR can be fully legitimate; this flags persistence + magnitude for review.",
  "stale": true,
  "latest_filing_period": "2018-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1516479/000156459019007444/0001564590-19-007444-index.htm",
    "form": "10-K",
    "filed": "2019-03-13"
  }
}